Versant Capital Management Inc Has $42,000 Stock Holdings in Centene Co. (NYSE:CNC)

Versant Capital Management Inc grew its stake in Centene Co. (NYSE:CNCFree Report) by 265.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 632 shares of the company’s stock after buying an additional 459 shares during the period. Versant Capital Management Inc’s holdings in Centene were worth $42,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Hohimer Wealth Management LLC increased its stake in shares of Centene by 1.1% in the fourth quarter. Hohimer Wealth Management LLC now owns 12,020 shares of the company’s stock valued at $892,000 after buying an additional 131 shares during the period. EP Wealth Advisors LLC grew its stake in Centene by 1.0% during the first quarter. EP Wealth Advisors LLC now owns 13,604 shares of the company’s stock worth $1,068,000 after purchasing an additional 133 shares during the period. Sandy Spring Bank grew its stake in Centene by 10.1% during the fourth quarter. Sandy Spring Bank now owns 1,629 shares of the company’s stock worth $121,000 after purchasing an additional 150 shares during the period. Fidelis Capital Partners LLC grew its stake in Centene by 5.0% during the first quarter. Fidelis Capital Partners LLC now owns 3,316 shares of the company’s stock worth $260,000 after purchasing an additional 158 shares during the period. Finally, Checchi Capital Advisers LLC grew its stake in Centene by 4.5% during the first quarter. Checchi Capital Advisers LLC now owns 3,910 shares of the company’s stock worth $307,000 after purchasing an additional 169 shares during the period. Institutional investors and hedge funds own 93.63% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CNC. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $90.00 target price on shares of Centene in a research note on Tuesday, July 23rd. Baird R W raised Centene to a “hold” rating in a research note on Thursday, May 30th. Truist Financial reduced their price objective on Centene from $92.00 to $89.00 and set a “buy” rating for the company in a research note on Monday, July 15th. TD Cowen raised their price objective on Centene from $80.00 to $89.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on Centene from $82.00 to $87.00 and gave the company a “hold” rating in a research note on Friday. Nine analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $84.36.

Get Our Latest Stock Report on CNC

Centene Price Performance

Shares of Centene stock traded down $1.99 during trading on Tuesday, hitting $75.44. 4,183,509 shares of the company were exchanged, compared to its average volume of 3,529,513. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.64. Centene Co. has a fifty-two week low of $60.83 and a fifty-two week high of $81.42. The stock has a market capitalization of $40.26 billion, a price-to-earnings ratio of 15.24, a P/E/G ratio of 1.00 and a beta of 0.50. The firm has a 50 day moving average price of $69.03 and a 200 day moving average price of $73.63.

Centene (NYSE:CNCGet Free Report) last announced its quarterly earnings results on Friday, July 26th. The company reported $2.42 earnings per share for the quarter, missing analysts’ consensus estimates of $2.44 by ($0.02). The company had revenue of $39.84 billion during the quarter, compared to analyst estimates of $36.83 billion. Centene had a net margin of 1.79% and a return on equity of 14.45%. The firm’s revenue for the quarter was up 5.9% compared to the same quarter last year. During the same quarter last year, the business earned $2.10 EPS. On average, equities analysts expect that Centene Co. will post 6.84 earnings per share for the current fiscal year.

Insider Transactions at Centene

In related news, Director Christopher J. Coughlin sold 878 shares of the business’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $76.75, for a total transaction of $67,386.50. Following the completion of the sale, the director now owns 25,504 shares of the company’s stock, valued at approximately $1,957,432. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Centene news, Director Christopher J. Coughlin sold 878 shares of the firm’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $76.75, for a total value of $67,386.50. Following the sale, the director now owns 25,504 shares in the company, valued at $1,957,432. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Kenneth J. Fasola sold 8,000 shares of the stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $77.62, for a total transaction of $620,960.00. Following the completion of the transaction, the president now owns 300,357 shares of the company’s stock, valued at $23,313,710.34. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Centene Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

See Also

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.